Document Detail


Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
MedLine Citation:
PMID:  21078694     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Background: There is increasing evidence on cerebrospinal fluid (CSF) oligoclonal IgM (OCIgM) predicting a more aggressive disease course in relapsing-remitting Multiple Sclerosis (MS), while there is a scarcity of data for primary progressive MS (PPMS). Objective: Our aim was to investigate the presence and possible prognostic value of CSF OCIgM in a group of PPMS and in a group of relapsing-onset MS patients. The possible prognostic role of other clinical and biological factors was also evaluated. Methods: We calculated the impact of single clinical and biological factors, including CSF OCIgM at onset, on the probability of reaching an Expanded Disability Status Scale of 3 and 4 in 45 PPMS and 104 relapsing-onset MS patients. Results: CSF OCIgM were found in only 13% of PPMS patients and did not influence the time taken to reach an Expanded Disability Status Scale of 3 and 4. Conversely, they were present in 46% of relapsing-onset MS patients and increased the risk of reaching an Expanded Disability Status Scale of 4. Clinical factors with a negative prognostic value in PPMS were age at onset <30 years and onset with pyramidal symptoms, while onset with sensory symptoms in relapsing-onset MS predicted a more favourable course. Conclusion: This study confirms that, in relapsing-onset MS patients, the presence of CSF OCIgM at onset predicts a worse disease course. In the cohort of PPMS patients, however, CSF OCIgM were rare, suggesting that heterogeneous pathogenetic mechanisms may be involved in the different MS forms.
Authors:
Patrizia Sola; Jessica Mandrioli; Anna M Simone; Diana Ferraro; Roberta Bedin; Rosanna Annecca; Maria G Venneri; Paolo F Nichelli; Elisa Merelli
Related Documents :
1707304 - Cell-mediated immune response to copolymer i in multiple sclerosis measured by the macr...
16631794 - Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cogniti...
17274174 - Detection rates of sexual dysfunction amongst patients with multiple sclerosis in an ou...
19419774 - Interferon-beta therapy up-regulates bdnf secretion from pbmcs of ms patients through a...
20432394 - Patients with coronary artery disease not amenable to traditional revascularization: pr...
20458624 - Peripheral arthritis in the course of inflammatory bowel diseases.
Publication Detail:
Type:  Journal Article     Date:  2010-11-15
Journal Detail:
Title:  Multiple sclerosis (Houndmills, Basingstoke, England)     Volume:  17     ISSN:  1477-0970     ISO Abbreviation:  Mult. Scler.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-03-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9509185     Medline TA:  Mult Scler     Country:  England    
Other Details:
Languages:  eng     Pagination:  303-11     Citation Subset:  IM    
Affiliation:
Department of Neurosciences, University of Modena and Reggio Emilia, Nuovo Ospedale Civile Sant'Agostino Estense, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Investigations of natural attenuation in groundwater near a landfill and implications for landfill p...
Next Document:  CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus.